Starpharma Holdings Stock Price, News & Analysis
Company Description
Starpharma Holdings (OTC Link: SPHRY) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $37.2M.
SPHRY stock has gained 690.7% over the past year. Shares last traded at $5.10.
This page provides a comprehensive overview of SPHRY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Starpharma Holdings (SPHRY) stock last traded at $5.10. Over the past 12 months, the stock has gained 690.7%. At a market capitalization of $37.2M, SPHRY is classified as a micro-cap stock with approximately 41.8M shares outstanding.
Latest News
Starpharma Holdings has 6 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial. View all SPHRY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Starpharma Holdings (SPHRY) currently stands at 98 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 52%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Starpharma Holdings (SPHRY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
SPHRY Company Profile & Sector Positioning
Starpharma Holdings (SPHRY) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing SPHRY often look at related companies in the same sector, including POOLBEG PHARMA PLC (POLBF), Sernova Biotherapeutics Inc (SEOVF), Relief Hldg (RLFTF), Relief Therapeut (RLFTY), and Covalon Technologies Ltd (CVALF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SPHRY's relative position within its industry.